Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of $1.80B. The enterprise value is $1.78B.
Market Cap$1.80B
Enterprise Value$1.78B
Share Statistics
PT Kalbe Farma Tbk has 46,813,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,813,390,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.97%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.97%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee2.75B
Profits Per Employee17.13K
Employee Count12,835
Asset Turnover1.15
Inventory Turnover3.04
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 8.7. PT Kalbe Farma Tbk’s PEG ratio is ―.
PE Ratio8.7
PS Ratio0.00
PB Ratio0.00
Price to FCF0.00
Price to Operating Cash Flow9.45
PEG Ratio―
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of 35.32T and earned 3.66T in profits. Earnings per share was 80.51.
Revenue35.32T
Gross Profit14.06T
Operating Income4.55T
Pretax Income4.78T
Net Income3.66T
EBITDA5.60T
Earnings Per Share (EPS)80.51
Cash Flow
In the last 12 months, operating cash flow was 3.33T and capital expenditures -875.67B, giving a free cash flow of 2.46T billion.
Operating Cash Flow3.33T
Free Cash Flow2.46T
Free Cash Flow per Share52.48
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of $0.001, resulting in a dividend yield of 2.07%
Dividend Per Share$0.001
Dividend Yield2.07%
Payout Ratio23.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change-16.13%
50-Day Moving Average0.05
200-Day Moving Average0.05
Relative Strength Index (RSI)97.97
Average Volume (3m)0.00
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Nov 3, 2026, TBA (Confirmed).
Last Earnings DateJul 31, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
PT Kalbe Farma Tbk as a current ratio of 3.47, with Debt / Equity ratio of 3.40%
Current Ratio3.47
Quick Ratio2.16
Debt to Market Cap<0.01
Net Debt to EBITDA-0.72
Interest Coverage Ratio128.95
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid 1.03T in taxes.
Income Tax1.03T
Effective Tax Rate0.22
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 9.04, with an EV/FCF ratio of 20.56.
EV to Sales1.43
EV to EBITDA9.04
EV to Free Cash Flow20.56
EV to Operating Cash Flow15.47
Balance Sheet
PT Kalbe Farma Tbk has $5.02T in cash and marketable securities with $531.72B in debt, giving a net cash position of $4.19T billion.
Cash & Marketable Securities$5.02T
Total Debt$531.72B
Net Cash$4.19T
Net Cash Per Share$89.47
Tangible Book Value Per Share$492.32
Margins
Gross margin is 37.52%, with operating margin of 12.87%, and net profit margin of 10.38%.
Gross Margin37.52%
Operating Margin12.87%
Pretax Margin13.53%
Net Profit Margin10.38%
EBITDA Margin15.84%
EBIT Margin13.63%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast8.01%
EPS Growth Forecast2.17%